Barbour Group - About
About
The Surgical Oncology Group has long standing interests in the management of oesophageal, gastric and pancreatic cancer, melanoma and soft tissue tumours.
Melanoma in particular has seen significant changes in management over the last decade with much needed improvements in survival. Our research group is involved in studies which seek to further improve patient outcomes. Genomics have underpinned major advances in our understanding of oesophageal, gastric and pancreatic cancers.
Incorporation of genomics into clinical practice is a necessary next step for precision cancer care.
The Surgical Oncology Group's research encompasses:
- Clinical research, including randomised controlled clinical trials
- Laboratory based research, including molecular biology
- Translational research integrating the laboratory and clinical domains, including radiomics
- Clinical practice guidelines.